Variant report

Variant	nsv1018615
Chromosome Location	chr9:16865804-16960970
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr9:16870940-16871146	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr9:16934659-16934853	K562	blood:	n/a	n/a
3	BACH1	chr9:16870063-16870262	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr9:16934628-16934951	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCL3	chr9:16921833-16922234	A549	lung:	n/a	chr9:16922220-16922229
6	BRCA1	chr9:16870026-16870092	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr9:16868060-16868408	A549	lung:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
8	CEBPB	chr9:16960006-16960332	IMR90	lung:	n/a	n/a
9	CEBPB	chr9:16939818-16939821	H1-hESC	embryonic stem cell:	n/a	n/a
10	CEBPB	chr9:16867953-16868427	IMR90	lung:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
11	CEBPB	chr9:16867927-16868542	A549	lung:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
12	CEBPB	chr9:16901687-16902029	IMR90	lung:	n/a	chr9:16901848-16901859
13	CEBPB	chr9:16868064-16868414	HepG2	liver:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
14	CEBPB	chr9:16927604-16927635	HepG2	liver:	n/a	n/a
15	CEBPB	chr9:16868041-16868355	ECC-1	luminal epithelium:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
16	CEBPB	chr9:16884994-16885796	IMR90	lung:	n/a	chr9:16885528-16885541
17	CEBPB	chr9:16873182-16873748	IMR90	lung:	n/a	chr9:16873434-16873445
18	CEBPB	chr9:16873229-16873384	A549	lung:	n/a	n/a
19	CEBPB	chr9:16868029-16868431	Hela-S3	cervix:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
20	CEBPB	chr9:16901689-16902044	Hela-S3	cervix:	n/a	chr9:16901848-16901859
21	CEBPB	chr9:16868073-16868432	MCF-7	breast:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
22	CEBPB	chr9:16901728-16901993	A549	lung:	n/a	chr9:16901848-16901859
23	CEBPB	chr9:16885265-16885574	Hela-S3	cervix:	n/a	chr9:16885528-16885541
24	CEBPB	chr9:16873187-16873697	Hela-S3	cervix:	n/a	chr9:16873434-16873445
25	CEBPB	chr9:16923221-16923363	IMR90	lung:	n/a	n/a
26	CEBPB	chr9:16868014-16868463	A549	lung:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
27	CEBPB	chr9:16901588-16902121	A549	lung:	n/a	chr9:16901848-16901859
28	CEBPB	chr9:16868084-16868399	H1-hESC	embryonic stem cell:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
29	CEBPB	chr9:16870607-16870634	H1-hESC	embryonic stem cell:	n/a	n/a
30	CEBPB	chr9:16868049-16868429	ECC-1	luminal epithelium:	n/a	chr9:16868232-16868241 chr9:16868232-16868243 chr9:16868230-16868241
31	CEBPB	chr9:16880221-16880332	H1-hESC	embryonic stem cell:	n/a	n/a
32	CHD1	chr9:16871061-16871345	H1-hESC	embryonic stem cell:	n/a	n/a
33	CHD1	chr9:16871612-16872256	H1-hESC	embryonic stem cell:	n/a	n/a
34	CHD1	chr9:16869619-16870710	H1-hESC	embryonic stem cell:	n/a	n/a
35	CHD2	chr9:16870873-16871230	H1-hESC	embryonic stem cell:	n/a	chr9:16871004-16871014
36	CHD2	chr9:16921955-16922155	H1-hESC	embryonic stem cell:	n/a	n/a
37	CHD2	chr9:16871622-16871908	H1-hESC	embryonic stem cell:	n/a	n/a
38	CREB1	chr9:16870578-16870957	A549	lung:	n/a	n/a
39	CTBP2	chr9:16869579-16870832	H1-hESC	embryonic stem cell:	n/a	n/a
40	CTCF	chr9:16870300-16870450	RPTEC	kidney:	n/a	n/a
41	CTCF	chr9:16870500-16870650	NHDF-neo	bronchial:	n/a	n/a
42	CTCF	chr9:16866780-16866930	HCFaa	heart:	n/a	n/a
43	CTCF	chr9:16952835-16952940	Hela-S3	cervix:	n/a	n/a
44	CTCF	chr9:16870631-16870745	SK-N-SH_RA	brain:	n/a	n/a
45	CTCF	chr9:16870480-16870630	RPTEC	kidney:	n/a	n/a
46	CTCF	chr9:16871640-16871790	HCPEpiC	choroid plexus:	n/a	n/a
47	CTCF	chr9:16870540-16870690	HCFaa	heart:	n/a	n/a
48	CTCF	chr9:16871880-16871975	A549	lung:	n/a	n/a
49	CTCF	chr9:16922140-16922290	HFF	foreskin:	n/a	n/a
50	CTCF	chr9:16866780-16866930	AG04449	skin:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:16870464-16870514	ECC-1	luminal epithelium:	n/a
2	chr9:16868891-16868941	HEEpiC	esophagus:	n/a
3	chr9:16872192-16872242	IMR90	lung:	fetal
4	chr9:16875612-16875662	T-47D	breast:	n/a
5	chr9:16870893-16870943	AG04449	skin:	fetal
6	chr9:16871185-16871235	HMEC	breast:	n/a
7	chr9:16870464-16870514	AoSMC	blood vessel:	n/a
8	chr9:16870091-16870141	GM12892	blood:	n/a
9	chr9:16870289-16870339	GM12878	blood:	n/a
10	chr9:16870289-16870339	GM19239	blood:	n/a
11	chr9:16870464-16870514	Jurkat	blood:	n/a
12	chr9:16870289-16870339	SAEC	small airway:	n/a
13	chr9:16868891-16868941	H1-hESC	embryonic stem cell:	embryo
14	chr9:16870289-16870339	ProgFib	skin:	n/a
15	chr9:16870289-16870339	NB4	blood:	n/a
16	chr9:16872192-16872242	LNCaP	prostate:	n/a
17	chr9:16868891-16868941	NHDF-neo	bronchial:	n/a
18	chr9:16871106-16871156	AG04449	skin:	fetal
19	chr9:16871106-16871156	HCM	heart:	n/a
20	chr9:16868891-16868941	Hela-S3	cervix:	n/a
21	chr9:16870893-16870943	HUVEC	blood vessel:	n/a
22	chr9:16870091-16870141	GM19239	blood:	n/a
23	chr9:16871106-16871156	HEEpiC	esophagus:	n/a
24	chr9:16870893-16870943	ProgFib	skin:	n/a
25	chr9:16868891-16868941	HCPEpiC	choroid plexus:	n/a
26	chr9:16868891-16868941	RPTEC	kidney:	n/a
27	chr9:16870289-16870339	T-47D	breast:	n/a
28	chr9:16871185-16871235	HPAEpiC	pulmonary alveolar:	n/a
29	chr9:16871185-16871235	SAEC	small airway:	n/a
30	chr9:16868891-16868941	GM06990	blood:	n/a
31	chr9:16875612-16875662	AG04450	lung:	fetal
32	chr9:16872192-16872242	H1-hESC	embryonic stem cell:	embryo
33	chr9:16871185-16871235	U87	brain:	n/a
34	chr9:16875612-16875662	SKMC	muscle:	n/a
35	chr9:16871185-16871235	Hepatocyte	liver:	n/a
36	chr9:16870289-16870339	AoSMC	blood vessel:	n/a
37	chr9:16875612-16875662	GM12878	blood:	n/a
38	chr9:16870464-16870514	HMEC	breast:	n/a
39	chr9:16871185-16871235	AG09309	skin:	n/a
40	chr9:16870893-16870943	AG10803	skin:	n/a
41	chr9:16871106-16871156	GM12891	blood:	n/a
42	chr9:16875612-16875662	HL-60	blood:	n/a
43	chr9:16868891-16868941	PFSK-1	brain:	n/a
44	chr9:16870464-16870514	RPTEC	kidney:	n/a
45	chr9:16868891-16868941	NHBE	bronchial:	n/a
46	chr9:16870464-16870514	K562	blood:	n/a
47	chr9:16870464-16870514	NHBE	bronchial:	n/a
48	chr9:16875612-16875662	Hela-S3	cervix:	n/a
49	chr9:16870091-16870141	NHBE	bronchial:	n/a
50	chr9:16870289-16870339	Hela-S3	cervix:	n/a

Variant related genes	Relation type
BNC2	TF binding region
BNC2	CpG island

Extended variants
information (count: 3839 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:3839 , 50 per page) page: 1 2 3 4 5 6 7 ... 77

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs183814760	chr9:16865815-16865816	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs140912666	chr9:16865829-16865830	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs557218842	chr9:16865860-16865861	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs188539370	chr9:16865923-16865924	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs546231486	chr9:16865925-16865926	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs559410828	chr9:16865978-16865979	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs532472397	chr9:16865985-16865986	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs540997201	chr9:16865994-16865995	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs181321051	chr9:16866020-16866021	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs112855401	chr9:16866021-16866022	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs529888749	chr9:16866043-16866044	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs34940661	chr9:16866075-16866076	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs548265142	chr9:16866135-16866136	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs115105749	chr9:16866163-16866164	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs186684713	chr9:16866174-16866175	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs78120433	chr9:16866183-16866184	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs543084236	chr9:16866248-16866249	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs551776424	chr9:16866250-16866251	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs570140658	chr9:16866318-16866319	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs534969837	chr9:16866327-16866328	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs191991311	chr9:16866331-16866332	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs573041303	chr9:16866333-16866334	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs115908143	chr9:16866349-16866350	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs144712989	chr9:16866358-16866359	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs537719324	chr9:16866388-16866389	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs558999730	chr9:16866417-16866418	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs546194385	chr9:16866425-16866426	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs138525858	chr9:16866426-16866427	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs114287169	chr9:16866434-16866435	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs577522995	chr9:16866454-16866455	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs1416741	chr9:16866459-16866460	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs7021274	chr9:16866464-16866465	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs140248563	chr9:16866481-16866482	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs181986179	chr9:16866499-16866500	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs529851516	chr9:16866522-16866523	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs187439482	chr9:16866530-16866531	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs563016546	chr9:16866570-16866571	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs530499313	chr9:16866614-16866615	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs367695915	chr9:16866627-16866628	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs544604315	chr9:16866629-16866630	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs150266540	chr9:16866633-16866634	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs59077570	chr9:16866658-16866659	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs370431722	chr9:16866661-16866662	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs572485923	chr9:16866662-16866663	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs542032115	chr9:16866679-16866680	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs55953726	chr9:16866680-16866681	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs569367489	chr9:16866683-16866684	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs61492173	chr9:16866684-16866685	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs62541921	chr9:16866685-16866686	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs563728027	chr9:16866693-16866694	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Breast cancer	21611746	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:804 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16860800-16867800	Weak transcription	Fetal Muscle Trunk	muscle
2	chr9:16862400-16868000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr9:16864200-16867600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr9:16864400-16866000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr9:16864400-16867800	Enhancers	iPS-18 Cell Line	embryonic stem cell
6	chr9:16864400-16867800	Enhancers	NHDF-Ad	bronchial
7	chr9:16864400-16868000	Enhancers	iPS-15b Cell Line	embryonic stem cell
8	chr9:16864600-16866600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
9	chr9:16864600-16867800	Enhancers	HUES64 Cell Line	embryonic stem cell
10	chr9:16864800-16866400	Enhancers	Rectal Smooth Muscle	rectum
11	chr9:16864800-16869200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr9:16864800-16869400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr9:16865000-16866400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr9:16865000-16866400	Weak transcription	Ovary	ovary
15	chr9:16865000-16866800	Weak transcription	NHEK	skin
16	chr9:16865000-16867400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
17	chr9:16865000-16867400	Enhancers	Fetal Lung	lung
18	chr9:16865000-16867600	Weak transcription	Psoas Muscle	Psoas
19	chr9:16865000-16867800	Weak transcription	H1 Cell Line	embryonic stem cell
20	chr9:16865000-16867800	Enhancers	HUES48 Cell Line	embryonic stem cell
21	chr9:16865000-16867800	Weak transcription	Fetal Muscle Leg	muscle
22	chr9:16865000-16867800	Enhancers	Osteobl	bone
23	chr9:16865000-16868000	Weak transcription	H9 Cell Line	embryonic stem cell
24	chr9:16865000-16868400	Weak transcription	Placenta Amnion	Placenta Amnion
25	chr9:16865000-16869400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr9:16865000-16869400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
27	chr9:16865000-16872000	Active TSS	Stomach Smooth Muscle	stomach
28	chr9:16865200-16866200	Enhancers	HSMM	muscle
29	chr9:16865200-16866400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
30	chr9:16865200-16866400	Weak transcription	Fetal Kidney	kidney
31	chr9:16865200-16866600	Weak transcription	Adipose Nuclei	Adipose
32	chr9:16865200-16867000	Enhancers	Muscle Satellite Cultured Cells	--
33	chr9:16865200-16868000	Weak transcription	Right Atrium	heart
34	chr9:16865200-16868000	Weak transcription	Skeletal Muscle Male	skeletal muscle
35	chr9:16865400-16866400	Weak transcription	HUES6 Cell Line	embryonic stem cell
36	chr9:16865400-16866400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr9:16865400-16866400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr9:16865400-16866400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
39	chr9:16865400-16867400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr9:16865600-16866400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
41	chr9:16865600-16866400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
42	chr9:16865600-16866400	Weak transcription	Fetal Stomach	stomach
43	chr9:16865600-16866400	Weak transcription	HSMMtube	muscle
44	chr9:16865600-16866600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
45	chr9:16865600-16866600	Weak transcription	Colon Smooth Muscle	Colon
46	chr9:16865600-16866800	Weak transcription	Duodenum Smooth Muscle	Duodenum
47	chr9:16865600-16867400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr9:16865600-16867800	Enhancers	NH-A	brain
49	chr9:16865800-16866200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
50	chr9:16865800-16866200	Weak transcription	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links